Project Details
Description
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients with Facioscapulohumeral Muscular Dystrophy
Status | Finished |
---|---|
Effective start/end date | 8/1/16 → 7/31/20 |
Funding
- ACCELERON PHARMA INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.